Wallis CJD - Search Results

1

Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform.

Hyndman ME, Paproski RJ, Kinnaird A, Fairey A, Marks L, Pavlovich CP, Fletcher SA, Zachoval R, Adamcova V, Stejskal J, Aprikian A, Wallis CJD, Pink D, Vasquez C, Beatty PH, Lewis JD. Hyndman ME, et al. Among authors: wallis cjd. NPJ Digit Med. 2024 Jun 20;7(1):163. doi: 10.1038/s41746-024-01167-9. NPJ Digit Med. 2024. PMID: 38902526 Free PMC article.

2

Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non-Indigenous men in a universal health care system.

Kiciak A, Clark W, Uhlich M, Letendre A, Littlechild R, Lightning P, Vasquez C, Singh R, Broomfield S, Martin AM, Huang G, Fairey A, Kolinsky M, Wallis CJD, Fung C, Hyndman E, Yip S, Bismar TA, Lewis J, Ghosh S, Kinnaird A. Kiciak A, et al. Among authors: wallis cjd. Cancer. 2023 Sep 15;129(18):2864-2870. doi: 10.1002/cncr.34812. Epub 2023 Jul 10. Cancer. 2023. PMID: 37424308 Free article.

3

Role of mpMRI of the prostate in screening for prostate cancer.

Wallis CJD, Haider MA, Nam RK. Wallis CJD, et al. Transl Androl Urol. 2017 Jun;6(3):464-471. doi: 10.21037/tau.2017.04.31. Transl Androl Urol. 2017. PMID: 28725588 Free PMC article. Review.

4

Prostate Cancer Genetics: A Review.

Wallis CJ, Nam RK. Wallis CJ, et al. EJIFCC. 2015 Mar 10;26(2):79-91. eCollection 2015 Mar. EJIFCC. 2015. PMID: 27683484 Free PMC article.

5

Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial.

Nam R, Patel C, Milot L, Hird A, Wallis C, Macinnis P, Singh M, Emmenegger U, Sherman C, Haider MA. Nam R, et al. BMJ Open. 2022 Nov 8;12(11):e059482. doi: 10.1136/bmjopen-2021-059482. BMJ Open. 2022. PMID: 36351725 Free PMC article. Clinical Trial.

6

Prostate cancer mortality rates in low- and favorable intermediate-risk active surveillance patients: a population-based competing risks analysis.

Sayyid RK, Benton JZ, Reed WC, Woodruff P, Terris MK, Wallis CJD, Klaassen Z. Sayyid RK, et al. Among authors: wallis cjd. World J Urol. 2023 Jan;41(1):93-99. doi: 10.1007/s00345-022-04228-4. Epub 2022 Dec 6. World J Urol. 2023. PMID: 36472651

7

A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.

Nam RK, Wallis CJ, Stojcic-Bendavid J, Milot L, Sherman C, Sugar L, Haider MA. Nam RK, et al. J Urol. 2016 Aug;196(2):361-6. doi: 10.1016/j.juro.2016.01.114. Epub 2016 Feb 13. J Urol. 2016. PMID: 26880413 Clinical Trial.

8

The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making.

Klaassen Z, Wallis CJD, Goldberg H, Chandrasekar T, Fleshner NE, Finelli A, Kulkarni GS, Detsky AS, Satkunasivam R. Klaassen Z, et al. Among authors: wallis cjd. Can Urol Assoc J. 2018 Dec;12(12):395-400. doi: 10.5489/cuaj.5351. Can Urol Assoc J. 2018. PMID: 29940136 Free PMC article.

9

Assessment of the epidemiological trends for prostate cancer using administrative data in Ontario.

Saad F, Bhindi B, Noonan K, Ong M, Castellano K, Kourkounakis A, Wallis CJD. Saad F, et al. Among authors: wallis cjd. Can Urol Assoc J. 2023 Apr;17(4):85-91. doi: 10.5489/cuaj.8099. Can Urol Assoc J. 2023. PMID: 36486175 Free PMC article.

10

Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer.

Roy S, Sun Y, Wallis CJD, Kishan AU, Morgan SC, Spratt DE, Malone S, Saad F. Roy S, et al. Among authors: wallis cjd. Cancers (Basel). 2023 Sep 2;15(17):4392. doi: 10.3390/cancers15174392. Cancers (Basel). 2023. PMID: 37686668 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters